Brain binding of anticonvulsants
- 1 August 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 30 (8) , 826
- https://doi.org/10.1212/wnl.30.8.826
Abstract
We investigated the binding of radioactive carbamazepine and valproic acid to brain homogenates, lipid-free extracts, brain lipid, and phospholipid fractions. Carbamazepine was bound to each of these components in a manner that is qualitatively indistinguishable from the binding of phenytoin, in spite of major physical-chemical differences in these molecules but consistent with the similarities in pharmacologic action. These data support the concept that protein and phospholipid binding may be required for the activity of membrane-stabilizing anticonvulsants. Neither valproic acid nor its metabolites exhibited binding to brain or to any of the individual components tested. Therefore, binding cannot explain the reported long duration of action of this drug.This publication has 21 references indexed in Scilit:
- Metabolism of Valproate Sodium in Rabbit, Rat, Dog, and ManEpilepsia, 1977
- Carbamazepine—A double‐blind comparison with phenytoinNeurology, 1977
- Effect of Anticonvulsants on Cortical Focal Seizure in CatsEpilepsia, 1977
- EFFECTS OF CHRONIC TREATMENT WITH AMINO‐OXYACETIC ACID OR SODIUM n‐DIPROPYLACETATE ON BRAIN GABA LEVELS AND THE DEVELOPMENT AND REGRESSION OF COBALT EPILEPTIC FOCI IN RATSJournal of Neurochemistry, 1976
- Valproic Acid: Reversibly Acting Drug?Epilepsia, 1976
- Diphenylhydantoin binding to brain lipids and phospholipidsBiochemical Pharmacology, 1976
- ENHANCEMENT OF DIPHENYLHYDANTOIN BINDING BY LIPID EXTRACTION1976
- Precision space‐filling atomic modelsBiopolymers, 1965
- Tic Douloureux Treated With New AnticonvulsantArchives of Neurology, 1963
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951